Progress in registration of mesenchymal stem cell therapy products and challenges to drugability

HAN Dongmei, ZHOU Di, ZHANG Yi, WEI Kaikun

PDF(810 KB)
Chinese Journal of Pharmacology and Toxicology
PDF(810 KB)
Chinese Journal of Pharmacology and Toxicology ›› 2025, Vol. 39 ›› Issue (4) : 296. DOI: 10.3867/j.issn.1000-3002.2025.04.007
REVIEWS

Progress in registration of mesenchymal stem cell therapy products and challenges to drugability

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2025, 39(4): 296 https://doi.org/10.3867/j.issn.1000-3002.2025.04.007

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(810 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉